Riskpilot← Back to searchSign inGet full accessEndospec AB
ABActiveOrg 5566688627Götgatan 67 2 TrDental practice care activities · NACE 8623Est. 20041 employees
Revenue 2024
SEK 2,2M
-12% vs 2023
EBITDA margin
10.9%
-73% vs 2023
Equity ratio
20.5%
Financial strength
Net profit 2024
SEK 185K
+150% vs 2023
| Revenue | SEK 2,2M | -12% |
| EBITDA | SEK 243K | -73% |
| Net profit | SEK 185K | +150% |
| Total assets | SEK 3,2M | -21% |
| Equity | SEK 651K | +40% |
| Employees | 1 | — |
Legal name
Endospec AB
Org number
5566688627
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
21 oktober 2004
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandvård, utbildning inom tandvårdsområdet samt bedriva handel med värdepapper ävensom idka därmed förenlig verksamhet.
Address
Götgatan 67 2 Tr
Phone
+468210201
Email
michaelahlquist@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 236 | 1 876 | 1 827 | 2 186 | 2 383 | 2 522 | 2 231 |
| Staff expenses | — | — | — | — | — | — | — | — | −272 |
| EBITDA | 1 413 | −1 508 | 819 | 513 | 259 | 340 | 717 | 887 | 243 |
| Depreciation & amort. | −43 | −21 | −21 | −21 | −14 | −14 | −26 | −68 | −68 |
| EBIT | 1 370 | −1 529 | 798 | 492 | 245 | 326 | 691 | 819 | 175 |
| Net financials | 31 | 22 | 16 | 6 | 21 | 10 | 9 | −2 012 | 1 |
| Profit before tax | 1 355 | −223 | 635 | 357 | 266 | 236 | 700 | −184 | 257 |
| Tax | −315 | −0 | −125 | −97 | −71 | −66 | −182 | −185 | −71 |
| Net profit | 1 040 | −223 | 510 | 260 | 195 | 170 | 518 | −369 | 185 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 528 | 3 896 | 4 242 | 4 275 | 4 424 | 4 578 | 4 581 | 4 012 | 3 184 |
| Equity | 1 707 | 1 483 | 1 993 | 2 253 | 2 448 | 2 617 | 3 135 | 466 | 651 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 2 536 | 2 413 | 2 069 | 1 702 | 1 656 | 1 541 | 1 026 | 3 126 | 2 192 |
| Total debt | 2 536 | 2 413 | 2 069 | 1 702 | 1 656 | 1 541 | 1 026 | 3 126 | 2 192 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20162024
Equity ratio
20.5%
This company
38.2%
Market median
-46% vs market
20162024
Return on equity
28.4%
This company
18.4%
Market median
+54% vs market
20162024
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20162024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20162024
Debt / equity
3.89×
This company
0.62×
Market median
-527% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BP | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Endospec Utbildning AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Endospec Utbildning AB
Endospec AB Board members of Endospec AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Patrik Zettergren | Audit | 0 companies |
| Carl Johan Bertil Ohlin | Deputy Board Member | 0 companies |
| Michael Lennart Ahlqvist | Board of Directors | 0 companies |